Skip to main content
logo
Kringle Pharma, Inc. (TYO:4884)
Japan flag Japan · Delayed Price · Currency is JPY
436.00
-4.00 (-0.91%)
Sep 16, 2026, 3:30 PM JST

Kringle Pharma Ratios and Metrics

Millions JPY. Fiscal year is Oct - Sep.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Market Capitalization
3,6893,1595,7604,3182,4213,919
Market Cap Growth
10.33%-45.16%33.41%78.32%-38.21%-
Enterprise Value
2,6211,5273,3041,937-271,690
Last Close Price
440.00462.00847.00798.00450.00907.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
PS Ratio
10.7843.8772.0062.586.1913.56
PB Ratio
2.952.422.732.140.871.56
P/TBV Ratio
2.952.422.732.140.871.56
P/OCF Ratio
----161.42-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
EV/Sales Ratio
7.6621.2141.3028.07-5.85

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Debt / Equity Ratio
-0.85-1.24-1.10-1.06-0.99-0.85
Asset Turnover
0.170.030.030.020.130.12
Inventory Turnover
0.33---0.270.39
Quick Ratio
9.7415.4018.5210.6117.4317.47
Current Ratio
17.1718.8521.5212.5219.8020.74
Return on Equity (ROE)
-61.23%-53.65%-36.63%-35.52%-12.50%-12.83%
Return on Assets (ROA)
-24.51%-23.50%-19.00%-19.07%-9.11%-8.98%
Return on Capital Employed (ROCE)
-42.80%-46.10%-31.10%-36.90%-14.00%-14.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Earnings Yield
-21.92%-29.00%-13.13%-19.78%-13.67%-7.68%
Buyback Yield / Dilution
-7.53%-6.92%-18.72%-11.00%-16.91%-7422.44%